Literature DB >> 10979120

Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas.

K C Ribeiro1, L P Kowalski, M R Latorre.   

Abstract

OBJECTIVES: To evaluate the impact of comorbidities, symptoms, and patients' characteristics on the 5-year overall survival of patients who underwent surgery for cancer of the oral tongue or floor of the mouth and to improve the survival estimates by the creation of a new staging system. PATIENTS AND METHODS: A cohort of 110 patients with squamous cell carcinoma of the oral tongue or floor of the mouth, who were admitted to a tertiary cancer hospital from January 1, 1990, to December 31, 1994, and who underwent surgery was studied. Multivariate analysis distinguished that patients' characteristics, symptoms, and comorbidities have a significant impact on 5-year overall survival. This functional severity index combined with the TNM stage created the extended clinical severity staging system.
RESULTS: The 5-year overall survival was 33.4%. Survival by TNM cancer stage was 64.6% (stage I), 67.5% (stage II), 28.9% (stage III), and 13.1% (stage IV) (chi(2) = 22.88, P<.001). When patients were categorized according to the extended clinical severity staging system, survival was as follows: 74.0% (stage 1), 47.1% (stage 2), 28.6% (stage 3), and 8.4% (stage 4) (chi(2) = 38.67, P<.001).
CONCLUSION: Clinical variables have a prognostic impact on oral cancer that is surgically treated, and the consistency of results confirms that survival estimates can be improved by the addition of these elements to the TNM classification, creating a more powerful and precise system in the determination of a prognosis.

Entities:  

Mesh:

Year:  2000        PMID: 10979120     DOI: 10.1001/archotol.126.9.1079

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  21 in total

1.  The prognostic role of phospho-Src family kinase analysis in tongue cancer.

Authors:  Ofer Ben-Izhak; Victoria Cohen-Kaplan; Rafael M Nagler
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

2.  A novel morbidity prediction model for head and neck oncosurgery.

Authors:  Mary Thomas; Nebu Abraham George; Balagopal Prabhakar Gowri; Preethi Sara George; Paul Sebastian
Journal:  Indian J Surg       Date:  2010-11-18       Impact factor: 0.656

3.  Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma.

Authors:  Yan Guo; Yuji Ma; Xuanhao Hu; Rongbo Song; Li Zhu; Ming Zhong
Journal:  Cancer Biol Ther       Date:  2018-01-15       Impact factor: 4.742

4.  The effect of age on survival and quality of life in elderly head and neck cancer patients: a long-term prospective study.

Authors:  Marc P van der Schroeff; Wynia Derks; Gerrit Jan Hordijk; Rob J de Leeuw
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-11       Impact factor: 2.503

5.  A comprehensive salivary analysis for oral cancer diagnosis.

Authors:  Thomas Shpitzer; Gideon Bahar; Raphael Feinmesser; Rafael M Nagler
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-04       Impact factor: 4.553

6.  Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age.

Authors:  Marilena Vered; Dan Dayan; Alex Dobriyan; Ran Yahalom; Bruria Shalmon; Iris Barshack; Lev Bedrin; Yoav P Talmi; Shlomo Taicher
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-07       Impact factor: 4.553

7.  Association of Symptoms and Clinical Findings With Anticipated Outcomes in Patients With Recurrent Head and Neck Cancer.

Authors:  Patrik Pipkorn; Jordan Licata; Dorina Kallogjeri; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-08-01       Impact factor: 6.223

8.  [Prognostic factors for oral squamous cell carcinoma].

Authors:  A W Eckert; M H W Lautner; R Dempf; J Schubert; U Bilkenroth
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

9.  Selecting a comparison group for 5-year oral and pharyngeal cancer survivors: two methods.

Authors:  Henrietta L Logan; Scott L Tomar; Myron Chang; Glenn E Turner; William M Mendenhall; Charles E Riggs
Journal:  BMC Med Res Methodol       Date:  2012-05-02       Impact factor: 4.615

10.  Surgical margins and survival after head and neck cancer surgery.

Authors:  Reina Haque; Richard Contreras; Michael P McNicoll; Evelyn C Eckberg; Diana B Petitti
Journal:  BMC Ear Nose Throat Disord       Date:  2006-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.